# PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites

> **NCT00561327** · — · UNKNOWN · sponsor: **German Heart Institute**

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** losartan

## Key facts

- **NCT ID:** NCT00561327
- **Lead sponsor:** German Heart Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-11-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00561327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00561327, "PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00561327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*